Evidence map›Paper›PMID 36422354›Full record

ArticleMicroorganisms2022

Nadica Kovačević, Vedrana Petrić, Maria Pete, Milica Popović, Aleksandra Plećaš-Đurić, Slađana Pejaković, Slavica Tomić, Dimitrije Damjanov, Dijana Kosijer, Milica Lekin

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microorganisms, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Antibiotic Usage and Healthcare-AssociatedAntibiotics (Basel, Switzerland) · 2025
    Article
  2. Microorganisms · 2023
    Article
  3. Incidence and Risk Factors forMicroorganisms · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Nadica KovačevićFaculty of Medicine, University of Novi Sad, 21137 Novi Sad, Serbia.ORCID 0000-0002-8886-3542
Vedrana PetrićFaculty of Medicine, University of Novi Sad, 21137 Novi Sad, Serbia.
Maria PeteFaculty of Medicine, University of Novi Sad, 21137 Novi Sad, Serbia.
Milica PopovićFaculty of Medicine, University of Novi Sad, 21137 Novi Sad, Serbia.
Aleksandra Plećaš-ĐurićFaculty of Medicine, University of Novi Sad, 21137 Novi Sad, Serbia.
Slađana PejakovićFaculty of Medicine, University of Novi Sad, 21137 Novi Sad, Serbia.
Slavica TomićFaculty of Medicine, University of Novi Sad, 21137 Novi Sad, Serbia.
Dimitrije DamjanovFaculty of Medicine, University of Novi Sad, 21137 Novi Sad, Serbia.
Dijana KosijerFaculty of Medicine, University of Novi Sad, 21137 Novi Sad, Serbia.
Milica LekinFaculty of Medicine, University of Novi Sad, 21137 Novi Sad, Serbia.
University of Novi Sad · RS

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this study was to investigate the differences of

Indexed as

Clostridioides difficile infectionCOVID-19outcomerisk factors

Identifiers

PMID36422354
PMCPMC9693082
OpenAlexW4309458582

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.